Thesis
I'm seriously looking at Teladoc (TDOC) for a potential rebound. With new leadership focused on cost-cutting and a growing telehealth market, this may be an undervalued opportunity. Sure, there are risks, but given the fundamentals, the reward seems worth a swing trade.